These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 25866368)
1. Heterodimerization of human orexin receptor 1 and kappa opioid receptor promotes protein kinase A/cAMP-response element binding protein signaling via a Gαs-mediated mechanism. Chen J; Zhang R; Chen X; Wang C; Cai X; Liu H; Jiang Y; Liu C; Bai B Cell Signal; 2015 Jul; 27(7):1426-38. PubMed ID: 25866368 [TBL] [Abstract][Full Text] [Related]
2. Novel signaling of dynorphin at κ-opioid receptor/bradykinin B2 receptor heterodimers. Ji B; Liu H; Zhang R; Jiang Y; Wang C; Li S; Chen J; Bai B Cell Signal; 2017 Feb; 31():66-78. PubMed ID: 28069442 [TBL] [Abstract][Full Text] [Related]
3. Heterodimerization of human apelin and kappa opioid receptors: roles in signal transduction. Li Y; Chen J; Bai B; Du H; Liu Y; Liu H Cell Signal; 2012 May; 24(5):991-1001. PubMed ID: 22200678 [TBL] [Abstract][Full Text] [Related]
4. Heterodimerization of mouse orexin type 2 receptor variants and the effects on signal transduction. Wang C; Pan Y; Zhang R; Bai B; Chen J; Randeva HS Biochim Biophys Acta; 2014 Mar; 1843(3):652-63. PubMed ID: 24368186 [TBL] [Abstract][Full Text] [Related]
5. Dual-agonist occupancy of orexin receptor 1 and cholecystokinin A receptor heterodimers decreases G-protein-dependent signaling and migration in the human colon cancer cell line HT-29. Bai B; Chen X; Zhang R; Wang X; Jiang Y; Li D; Wang Z; Chen J Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1153-1164. PubMed ID: 28288880 [TBL] [Abstract][Full Text] [Related]
6. The orexin 1 receptor modulates kappa opioid receptor function via a JNK-dependent mechanism. Robinson JD; McDonald PH Cell Signal; 2015 Jul; 27(7):1449-56. PubMed ID: 25857454 [TBL] [Abstract][Full Text] [Related]
7. Orexin-corticotropin-releasing factor receptor heteromers in the ventral tegmental area as targets for cocaine. Navarro G; Quiroz C; Moreno-Delgado D; Sierakowiak A; McDowell K; Moreno E; Rea W; Cai NS; Aguinaga D; Howell LA; Hausch F; Cortés A; Mallol J; Casadó V; Lluís C; Canela EI; Ferré S; McCormick PJ J Neurosci; 2015 Apr; 35(17):6639-53. PubMed ID: 25926444 [TBL] [Abstract][Full Text] [Related]
8. Heterodimerization of the kappa opioid receptor and neurotensin receptor 1 contributes to a novel β-arrestin-2-biased pathway. Liu H; Tian Y; Ji B; Lu H; Xin Q; Jiang Y; Ding L; Zhang J; Chen J; Bai B Biochim Biophys Acta; 2016 Nov; 1863(11):2719-2738. PubMed ID: 27523794 [TBL] [Abstract][Full Text] [Related]
9. Ghrelin Through GHSR1a and OX1R Heterodimers Reveals a Gαs-cAMP-cAMP Response Element Binding Protein Signaling Pathway Xue Q; Bai B; Ji B; Chen X; Wang C; Wang P; Yang C; Zhang R; Jiang Y; Pan Y; Cheng B; Chen J Front Mol Neurosci; 2018; 11():245. PubMed ID: 30065627 [TBL] [Abstract][Full Text] [Related]
10. Distinct Neuromodulatory Effects of Endogenous Orexin and Dynorphin Corelease on Projection-Defined Ventral Tegmental Dopamine Neurons. Mohammadkhani A; Qiao M; Borgland SL J Neurosci; 2024 Sep; 44(39):. PubMed ID: 39187377 [TBL] [Abstract][Full Text] [Related]
11. Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders. Xu TR; Yang Y; Ward R; Gao L; Liu Y Cell Signal; 2013 Dec; 25(12):2413-23. PubMed ID: 23917208 [TBL] [Abstract][Full Text] [Related]
12. Agonist potency differentiates G protein activation and Ca2+ signalling by the orexin receptor type 1. Magga J; Bart G; Oker-Blom C; Kukkonen JP; Akerman KE; Näsman J Biochem Pharmacol; 2006 Mar; 71(6):827-36. PubMed ID: 16430869 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons. Sasaki T; Kotera J; Omori K J Neurochem; 2004 Apr; 89(2):474-83. PubMed ID: 15056290 [TBL] [Abstract][Full Text] [Related]
14. A novel diol-derivative of chalcone produced by bioconversion, 3-(2,3-dihydroxyphenyl)-1-phenylpropan-1-one, activates PKA/MEK/ERK signaling and antagonizes Abeta-inhibition of the cascade in cultured rat CNS neurons. Al Rahim M; Nakajima A; Misawa N; Shindo K; Adachi K; Shizuri Y; Ohizumi Y; Yamakuni T Eur J Pharmacol; 2008 Dec; 600(1-3):10-7. PubMed ID: 18948095 [TBL] [Abstract][Full Text] [Related]
15. alpha-Tocopherol decreases the somatostatin receptor-effector system and increases the cyclic AMP/cyclic AMP response element binding protein pathway in the rat dentate gyrus. Hernández-Pinto AM; Puebla-Jiménez L; Arilla-Ferreiro E Neuroscience; 2009 Aug; 162(1):106-17. PubMed ID: 19393293 [TBL] [Abstract][Full Text] [Related]
16. Transmembrane peptide 4 and 5 of APJ are essential for its heterodimerization with OX1R. Wan L; Xu F; Liu C; Ji B; Zhang R; Wang P; Wu F; Pan Y; Yang C; Wang C; Chen J Biochem Biophys Res Commun; 2020 Jan; 521(2):408-413. PubMed ID: 31668922 [TBL] [Abstract][Full Text] [Related]
17. Signaling transduction regulated by 5-hydroxytryptamine 1A receptor and orexin receptor 2 heterodimers. Wang QQ; Wang CM; Cheng BH; Yang CQ; Bai B; Chen J Cell Signal; 2019 Feb; 54():46-58. PubMed ID: 30481562 [TBL] [Abstract][Full Text] [Related]
18. The signalling profile of recombinant human orexin-2 receptor. Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270 [TBL] [Abstract][Full Text] [Related]
19. GIV/Girdin activates Gαi and inhibits Gαs via the same motif. Gupta V; Bhandari D; Leyme A; Aznar N; Midde KK; Lo IC; Ear J; Niesman I; López-Sánchez I; Blanco-Canosa JB; von Zastrow M; Garcia-Marcos M; Farquhar MG; Ghosh P Proc Natl Acad Sci U S A; 2016 Sep; 113(39):E5721-30. PubMed ID: 27621449 [TBL] [Abstract][Full Text] [Related]
20. A hallmark of immunoreceptor, the tyrosine-based inhibitory motif ITIM, is present in the G protein-coupled receptor OX1R for orexins and drives apoptosis: a novel mechanism. Voisin T; El Firar A; Rouyer-Fessard C; Gratio V; Laburthe M FASEB J; 2008 Jun; 22(6):1993-2002. PubMed ID: 18198212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]